AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.2 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Inhibition of ITGA2 suppresses cervical tumorigenesis and metastasis by targeting the AKT/mTOR signaling pathway

Haixia Luoa,1Jingjing Changa,1Yiting Rena,1Xiu ZhangaYuanxing LiaMiao HuoaHongyuan WangaXin YangbJianbing LiucQingmei ZhangdYueyang ZhaoaWei Wanga( )
Department of Obstetrics and Gynecology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China
Pathology Department, School of Medicine, Stanford University, California 94305, USA
School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi 030001, China
School of Applied Science, Taiyuan University of Science and Technology, Taiyuan, Shanxi 030024, China

Peer review under responsibility of Chongqing Medical University.

1 These authors contributed equally to this work.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases
Article number: 101328

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Luo H, Chang J, Ren Y, et al. Inhibition of ITGA2 suppresses cervical tumorigenesis and metastasis by targeting the AKT/mTOR signaling pathway. Genes & Diseases, 2025, 12(2): 101328. https://doi.org/10.1016/j.gendis.2024.101328

617

Views

25

Downloads

2

Crossref

2

Web of Science

2

Scopus

0

CSCD

Received: 05 September 2023
Published: 18 May 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).